INSM logo

INSM
Insmed Inc

3,043
Mkt Cap
$23.39B
Volume
3.69M
52W High
$212.75
52W Low
$65.56
PE Ratio
-19.07
INSM Fundamentals
Price
$109.53
Prev Close
$107.91
Open
$107.55
50D MA
$137.98
Beta
0.76
Avg. Volume
1.8M
EPS (Annual)
-$6.42
P/B
33.65
Rev/Employee
$364,436.90
$33,962.33
Loading...
Loading...
News
all
press releases
Competitive Pressures Prompt Truist to Cut Target on Insmed (INSM)
Competitive Pressures Prompt Truist to Cut Target on Insmed (INSM...
News Placeholder
More News
News Placeholder
Zoetis, Insmed, And HubSpot Are Among Top 10 Large-Cap Losers Last Week (May 4-May 8): Are The Others In Your Portfolio?
Weak earnings, soft guidance and analyst target cuts triggered sharp selloffs across healthcare, software, networking and industrial stocks last week, led by Zoetis, Insmed and HubSpot.read more...
News Placeholder
Insmed's Q1 Earnings Beat, Sales Miss Estimates, Stock Tanks 23%
INSM stock plunges 23% after Q1 sales miss estimates despite 230% revenue growth and strong Brinsupri uptake.
News Placeholder
Insmed (INSM) Q1 2026 Earnings Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
News Placeholder
Insmed (INSM) Reports Q1 Loss, Misses Revenue Estimates
Insmed (INSM) delivered earnings and revenue surprises of +15.86% and -0.70%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
News Placeholder
Insmed Reports First-Quarter 2026 Financial Results and Provides Business Update
Insmed Reports First-Quarter 2026 Financial Results and Provides Business Update Insmed Reports First-Quarter 2026 Financial Results and Provides Business Update PR Newswire BRIDGEWATER, N.J., May 7...
News Placeholder
Insmed and Ty Pennington Team Up to Drive Awareness and Proper Diagnosis of Bronchiectasis
Insmed and Ty Pennington Team Up to Drive Awareness and Proper Diagnosis of Bronchiectasis Insmed and Ty Pennington Team Up to Drive Awareness and Proper Diagnosis of Bronchiectasis PR Newswire...
News Placeholder
Strs Ohio Has $9.05 Million Stake in Insmed, Inc. $INSM
Strs Ohio raised its holdings in Insmed, Inc. (NASDAQ:INSM - Free Report) by 76.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 52,016 shares of the biopharmaceutical company's stock after buying an additional 22,562 shares...
News Placeholder
PFA Pension Forsikringsaktieselskab Acquires Shares of 48,330 Insmed, Inc. $INSM
PFA Pension Forsikringsaktieselskab bought a new position in shares of Insmed, Inc. (NASDAQ:INSM - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 48,330 shares of the biop...
News Placeholder
Insmed to Present Data Across Its Respiratory Portfolio, Including Late-Breaking ARIKAYCE Results from Phase 3b ENCORE Study, at the American Thoracic Society International Conference 2026
Insmed to Present Data Across Its Respiratory Portfolio, Including Late-Breaking ARIKAYCE Results from Phase 3b ENCORE Study, at the American Thoracic Society International Conference 2026 Insmed to...
<
1
2
...
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available